Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis
1. Initiation of centrally acting analgesics in patients with osteoarthritis (OA) was associated with a higher long-term risk of total ...
Tag: selective serotonin reuptake inhibitor (SSRI)
Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression
1. Genotype-guided prescribing of selective serotonin reuptake inhibitors (SSRIs) may improve treatment response in children and adults with depression. Evidence ...
2 Minute Medicine Rewind May 11, 2026
Adjuvanted vs High-Dose Influenza Vaccines in Older US Adults 1. Adjuvanted influenza vaccines did not differ significantly in effectiveness compared ...
2 Minute Medicine Rewind December 1st, 2025
Efficacy of standard care versus acoustic therapy on acute tinnitus in idiopathic sudden sensorineural hearing loss: a randomized controlled trial ...
Use of selective serotonin reuptake inhibitors during breastfeeding is not associated with reduced cognitive performance in children
1. In this prospective cohort study, postpartum selective serotonin reuptake inhibitors (SSRIs) use during breastfeeding was not associated with reduced ...
Commonly cited medication triggers may not increase risk of microscopic colitis among older adults
1. In this series of target trial emulations, several common medications were not found to significantly affect the risk of ...
Selective serotonin reuptake inhibitor use may be associated with reduced mortality from COVID-19 infection
1. The relative risk of death for patients prescribed a selective serotonin reuptake inhibitor (SSRI) was reduced compared to matched ...
#VisualAbstract: In Utero Antidepressants and Neurodevelopmental Outcomes in Kindergarteners
1. Children with in utero exposure to selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs) demonstrated greater ...
Adverse neurodevelopmental outcomes linked to prenatal exposure to antidepressants
1. Children with in utero exposure to selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs) demonstrated greater ...
SAGE-217 reduces depressive symptoms in patients with major depression within 2 weeks
1. Patients with major depression randomized to receive SAGE-217, a positive allosteric modulator of γ-aminobutyric acid (GABA) type A receptors, ...
